PDF(1157 KB)
PDF(1157 KB)
PDF(1157 KB)
白细胞计数对新生儿早发型败血症的诊断界值探讨
Cut-off value of white blood cell count in the diagnosis of early-onset sepsis in neonates
目的 评价白细胞（WBC）计数在新生儿早发型败血症（EOS）诊断中的临床应用价值，探讨WBC诊断的上限界值。方法 回顾性选取2019年1月至2020年3月收治的新生儿EOS患儿306例，以同期580例非感染患儿作为对照组，比较两组患儿一般情况、WBC计数等。根据2003年《新生儿败血症诊疗方案》（简称2003年版诊疗方案）及《新生儿败血症诊断及治疗专家共识（2019年版）》（简称2019年版专家共识）标准分别对WBC计数的诊断价值进行评价。结果 根据两种不同诊疗方案，WBC计数的阳性率均较低（分别为51.3%和32.0%），但特异度均较高（分别为93.3%和98.6%）。经受试者工作特征曲线分析显示，2003年版诊疗方案WBC计数曲线下面积大于2019年版专家共识（P < 0.05）。结论 WBC计数在诊断EOS中的诊断上限界值以2003年《新生儿败血症诊疗方案》中≥25×109/L更为合理。
Objective To study the clinical significance and cut-off value of white blood cell (WBC) count in the diagnosis of early-onset sepsis (EOS) in neonates. Methods A retrospective analysis was performed on 306 neonates with EOS who were admitted from January 2019 to March 2020. A total of 580 children without infection who were admitted during the same period of time were enrolled as the control group. General status and WBC count were compared between the two groups. The diagnostic value of WBC count was analyzed based on the diagnostic and therapeutic protocol of neonatal sepsis in 2003 (referred to as the 2003 diagnostic and therapeutic protocol) and the expert consensus on the diagnosis and treatment of neonatal sepsis (2019 edition) (referred to as the 2019 expert consensus). Results According to the two different diagnosis and treatment protocols, the statistical analysis showed that WBC count had a relatively positive rate (51.3% and 32.0% respectively) but a relatively high specificity (93.3% and 98.6% respectively). The receiver operating characteristic (ROC) curve analysis showed that the area under the ROC curve of WBC count in the 2003 diagnostic and therapeutic protocol was larger than that in the 2019 expert consensus (P < 0.05). Conclusions The cut-off value of WBC ≥ 25×109/L in the 2003 diagnostic and therapeutic protocol is more reasonable in the diagnosis of EOS.
早发型败血症 / 白细胞计数 / 诊断 / 界值 / 新生儿
Early-onset sepsis / White blood cell count / Diagnosis / Cut-off value / Neonate
[1] Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis:a systematic review[J]. Lancet Respir Med, 2018, 6(3):223-230.
[2] Al-Shamahy HA, Sabrah AA, Al-Robasi AB, et al. Types of bacteria associated with neonatal sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their antimicrobial profile[J]. Sultan Qaboos Univ Med J, 2012, 12(1):48-54.
[3] Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England:the NeonIN surveillance network[J]. Arch Dis Child Fetal Neonatal Ed, 2011, 96(1):F9-F14.
[4] Kohli-Kochhar R, Omuse G, Revathi G. A ten-year review of neonatal bloodstream infections in a tertiary private hospital in Kenya[J]. J Infect Dev Ctries, 2011, 5(11):799-803.
[5] Sgro M, Shah PS, Campbell D, et al. Early-onset neonatal sepsis:rate and organism pattern between 2003 and 2008[J]. J Perinatol, 2011, 31(12):794-798.
[6] Morioka I, Morikawa S, Miwa A, et al. Culture-proven neonatal sepsis in Japanese neonatal care units in 2006-2008[J]. Neonatology, 2012, 102(1):75-80.
[7] Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis[J]. Pediatr Infect Dis J, 2012, 31(8):799-802.
[8] 中华医学会儿科学分会新生儿学组, 中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019年版)[J]. 中华儿科杂志, 2019, 57(4):252-257.
[9] 中华医学会儿科学分会新生儿学组, 中华医学会中华儿科杂志编辑委员会. 新生儿败血症诊疗方案[J]. 中华儿科杂志, 2003, 41(12):897-899.
[10] Wang J, Yu J, Fan J, et al. Evaluation of altitude-appropriate reference ranges for neutrophils in diagnosis of sepsis in very low birth weight infants:a multicenter retrospective study[J]. PLoS One, 2017, 12(2):e0171571.
[11] Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008[J]. Pediatr Infect Dis J, 2011, 30(11):937-941.
[12] Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis:the burden of group B streptococcal and E. coli disease continues[J]. Pediatrics, 2011, 127(5):817-826.
[13] Meem M, Modak JK, Mortuza R, et al. Biomarkers for diagnosis of neonatal infections:a systematic analysis of their potential as a point-of-care diagnostics[J]. J Glob Health, 2011, 1(2):201-209.
[14] Mussap M, Noto A, Cibecchini F, et al. The importance of biomarkers in neonatology[J]. Semin Fetal Neonatal Med, 2013, 18(1):56-64.
[15] Resch B, B R, N H. Comparison between pathogen associated laboratory and clinical parameters in early-onset sepsis of the newborn[J]. Open Microbiol J, 2016, 10:133-139.
[16] Gerdes JS. Diagnosis and management of bacterial infections in the neonate[J]. Pediatr Clin North Am, 2004, 51(4):939-ix.
[17] Odabasi IO, Bulbul A. Neonatal sepsis[J]. Sisli Etfal Hastan Tip Bul, 2020, 54(2):142-158.
[18] 尹运堂, 龚放, 余加林, 等. 联合非特异性指标对新生儿败血症早期诊断的价值研究[J]. 重庆医学, 2015, 44(33):4624-4626.
[19] Yang AP, Liu J, Yue LH, et al. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis[J]. Clin Chem Lab Med, 2016, 54(2):345-351.
[20] Al-Zahrani AKh, Ghonaim MM, Hussein YM, et al. Evaluation of recent methods versus conventional methods for diagnosis of early-onset neonatal sepsis[J]. J Infect Dev Ctries, 2015, 9(4):388-393.
